PortfoliosLab logoPortfoliosLab logo
UDOW vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

UDOW vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UDOW achieves a 12.27% return, which is significantly higher than CURE's -18.38% return. Over the past 10 years, UDOW has outperformed CURE with an annualized return of 23.30%, while CURE has yielded a comparatively lower 11.65% annualized return.


UDOW

1D
-3.38%
1M
10.84%
YTD
12.27%
6M
12.78%
1Y
53.13%
3Y*
33.01%
5Y*
12.75%
10Y*
23.30%

CURE

1D
2.17%
1M
4.39%
YTD
-18.38%
6M
-18.70%
1Y
21.60%
3Y*
-0.15%
5Y*
0.21%
10Y*
11.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UDOW vs. CURE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UDOW
ProShares UltraPro Dow30
12.27%24.46%28.47%32.72%-32.39%65.67%-17.15%75.24%-23.86%99.07%
CURE
Direxion Daily Healthcare Bull 3x Shares
-18.38%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between UDOW and CURE is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.51

Correlation (3Y)
Calculated over the trailing 3-year period

0.63

Correlation (5Y)
Calculated over the trailing 5-year period

0.68

Correlation (10Y)
Calculated over the trailing 10-year period

0.69

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2011

0.71

The correlation between UDOW and CURE shifts across timeframes, from 0.51 (1 year) to 0.71 (all time), reflecting how their relationship changes across market environments.

UDOW vs. CURE - Sectors Allocation Comparison


Sectors
UDOW
CURE

Financial Services

27.2%

-

Industrials

18.4%

-

Technology

17.1%

-

Healthcare

13.1%
100.0%

Consumer Cyclical

11.6%

-

Consumer Defensive

4.4%

-

Basic Materials

4.0%

-

Energy

2.4%

-

Communication Services

1.9%

-

Real Estate

-

-

Utilities

-

-

Financial Services

UDOW
27.2%
CURE

-

Industrials

UDOW
18.4%
CURE

-

Technology

UDOW
17.1%
CURE

-

Healthcare

UDOW
13.1%
CURE
100.0%

Consumer Cyclical

UDOW
11.6%
CURE

-

Consumer Defensive

UDOW
4.4%
CURE

-

Basic Materials

UDOW
4.0%
CURE

-

Energy

UDOW
2.4%
CURE

-

Communication Services

UDOW
1.9%
CURE

-

Real Estate

UDOW

-

CURE

-

Utilities

UDOW

-

CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UDOW vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UDOW
UDOW Risk / Return Rank: 4040
Overall Rank
UDOW Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
UDOW Sortino Ratio Rank: 4040
Sortino Ratio Rank
UDOW Omega Ratio Rank: 3838
Omega Ratio Rank
UDOW Calmar Ratio Rank: 3838
Calmar Ratio Rank
UDOW Martin Ratio Rank: 4141
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 1818
Overall Rank
CURE Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 1919
Sortino Ratio Rank
CURE Omega Ratio Rank: 1818
Omega Ratio Rank
CURE Calmar Ratio Rank: 1717
Calmar Ratio Rank
CURE Martin Ratio Rank: 1717
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UDOW vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UDOWCUREDifference
Sharpe ratioReturn per unit of total volatility

+0.98

Sortino ratioReturn per unit of downside risk

+1.05

Omega ratioGain probability vs. loss probability

1.25

1.12

+0.14

Calmar ratioReturn relative to maximum drawdown

1.90

0.70

+1.20

Martin ratioReturn relative to average drawdown

6.75

1.61

+5.14

UDOW vs. CURE - Sharpe Ratio Comparison

The current UDOW Sharpe Ratio is 1.48, which is higher than the CURE Sharpe Ratio of 0.50. The chart below compares the historical Sharpe Ratios of UDOW and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


UDOWCUREDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.48

0.50

+0.98

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.29

0.00

+0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

0.24

+0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

0.53

0.46

+0.07

Drawdowns

UDOW vs. CURE - Drawdown Comparison

The maximum UDOW drawdown since its inception was -80.29%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UDOW and CURE.


Loading charts...

Drawdown Indicators


UDOWCUREDifference

Max Drawdown

Largest peak-to-trough decline

-80.29%

-69.19%

-11.10%

Max Drawdown (1Y)

Largest decline over 1 year

-28.07%

-31.10%

+3.03%

Max Drawdown (3Y)

Largest decline over 3 years

-44.83%

-51.93%

+7.10%

Max Drawdown (5Y)

Largest decline over 5 years

-55.79%

-52.23%

-3.56%

Max Drawdown (10Y)

Largest decline over 10 years

-80.29%

-69.19%

-11.10%

Current Drawdown

Current decline from peak

-3.38%

-35.21%

+31.83%

Average Drawdown

Average peak-to-trough decline

-14.39%

-18.15%

+3.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.90%

13.43%

-5.53%

Volatility

UDOW vs. CURE - Volatility Comparison

The current volatility for ProShares UltraPro Dow30 (UDOW) is 8.80%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 11.99%. This indicates that UDOW experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UDOWCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.80%

11.99%

-3.19%

Volatility (6M)

Calculated over the trailing 6-month period

27.61%

29.83%

-2.22%

Volatility (1Y)

Calculated over the trailing 1-year period

36.12%

43.19%

-7.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.19%

43.69%

+0.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.76%

49.51%

+2.25%

UDOW vs. CURE - Expense Ratio Comparison

UDOW has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.


Dividends

UDOW vs. CURE - Dividend Comparison

UDOW's dividend yield for the trailing twelve months is around 1.21%, less than CURE's 1.31% yield.


PositionTTM20252024202320222021202020192018201720162015
CURE
Direxion Daily Healthcare Bull 3x Shares
1.31%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%
UDOW
ProShares UltraPro Dow30
1.21%1.38%0.95%0.95%0.83%0.26%0.19%0.61%0.73%0.13%0.26%0.21%

Frequently Asked Questions


UDOW and CURE have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (11.99%) compared to UDOW (8.80%). In terms of maximum drawdown, UDOW dropped -80.29% vs CURE's -69.19%.

On 10-year performance, UDOW leads with 23.30% vs 11.65% for CURE. On fees, UDOW is cheaper at 0.95% per year. On volatility, UDOW has been the lower-risk option at 8.80%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, UDOW has performed better with a 23.30% return vs 11.65%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

UDOW is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.31%, compared with 1.21% for UDOW.

UDOW tracks Dow Jones Industrial Average (300%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for UDOW and 1.08% for CURE.

UDOW currently has the higher Sharpe Ratio (1.48 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UDOW and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer